Gidazepam
Aliases: Hydazepam, Gidazepam ic
Summary
Gidazepam is an atypical benzodiazepine developed in the Soviet Union, licensed for use in Russia and Ukraine under the brand name Gidazepam IC. It functions as a prodrug metabolized to desalkylgidazepam (bromo-nordazepam). Unlike typical benzodiazepines, gidazepam has minimal sedative and hypnotic effects, making it suitable for daytime use.
Dose Information
Onset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset |
|---|---|---|---|---|
| Oral | 30-60 min | 1-2 hrs | 1-4 hrs | 6-12 hrs |
Effect Profile
Scores (1–10) curated from multiple sources:
- Effect keyword matching from PsychonautWiki catalog
- Weighted by importance: core (×3), major (×2), minor (×1)
Strong anxiolysis and cognitive impairment with moderate euphoria, mild sedation
Tolerance
Tolerance Decay
Tolerance builds with regular daily or near-daily use within weeks and decays slowly over several weeks after cessation. Values are heuristic aggregates based on benzodiazepine-class data rather than gidazepam-specific trials; expect interindividual variability.
Cross-Tolerances
Effects
- Muscle relaxation
- Physical euphoria
- Stimulation
- Anxiolytic
- Muscle Relaxant
- Motor impairment
- Respiratory depression
- Sedation
- Sedative
- Dystaxia
- Anxiety suppression
- Cognitive clarity
- Reduced anxiety
- Emotion suppression
- Motor control loss
- Amnesia
- Dizziness
- Thought deceleration
- Compulsive redosing
- Delusions of sobriety
- Increased libido
- Appetite enhancement
- Disinhibition
- Acuity suppression
- Visual acuity suppression
- Decreased Libido
- Acuity Suppression
- Double vision
- Dulled perception
- Perception of bodily heaviness